Note: Ingredients listed on restricted chemical lists
EC/CAS
202-496-6/96-29-7
Name of the chemical
2-Butanonoxim (2020/1182)
Concentration
>=1-<10
EC/CAS
209-136-7/556-67-2
Name of the chemical
D4
Concentration
>=0,1-<1
General Information
Revision date
2022-02-11
Product name
BYGGSILIKON HVIT
1.2.1 Relevant identified uses
Sealant
Icons in SDS
Company Information
company name
Würth Norge AS
e-mail address of the competent person responsible for the Safety Data Sheet
prodsafe@wuerth.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H350, H412
Hazard statements
Code
Statements
H350
May cause cancer
Section 2
CLP CLASSIFICATION
Carcinogenicity, Category 1B H350: May cause cancer. Long-term (chronic) aquatic hazard, Cat- H412: Harmful to aquatic life with long lasting ef- egory 3 fects.
2.2 Label elements
REGULATION (EC) No 1272/2008)
Signal word
Danger
Hazard statements
H350 May cause cancer. H412 Harmful to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Hazardous Ingredients
Butan-2-one O,O',O''-(vinylsilylidyne)trioxime Ethyl methyl ketoxime Butan-2-one O,O',O''-(methylsilylidyne)trioxime
Additional information
EUH208
Contains
Ethyl methyl ketoxime, N-(3-(Trimethoxysilyl)propyl)ethylenediamine, Butan-2-one O,O',O''-(vinylsilylidyne)trioxime, Butan-2-one O,O',O''- (methylsilylidyne)trioxime. May produce an allergic reaction.
2.3 Other hazards
This substance/mixture contains components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB).
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
